Regarding changes in the Management Board of Grindeks subsidiary Kalceks

Regarding changes in the Management Board of Grindeks subsidiary Kalceks

19/02/2020

As of February 18, the Management Board of JSC Kalceks, a subsidiary of JSC Grindeks, has been changed – the member of the Management Board Egils Kopstals has been appointed as the new Chairman of the Board of JSC Kalceks.

Kaspars Kuprevics, the Quality and R&D Director/Qualified person has also joined JSC Kalceks Management Board. Juris Hmelnickis, who was the Chairman of the Board of JSC Kalceks since 2014 and who on 4 February 2020 was approved by the Supervisory Council of JSC Grindeks as the new Chairman of the Board of JSC Grindeks, will continue to actively participate in JSC Kalceks, performing the duties of a member of the Management Board.

Egils Kopstals has 20 years of experience in JSC Grindeks group as he joined JSC Kalceks in 2000. Simultaneously with working at JSC Kalceks has was also the Head of Investment Department of JSC Grindeks from 2007 to 2012 and the Chief Economist from 2012. Since 2018 Egils Kopstals has been working at JSC Kalceks only.

Kaspars Kuprevics is the Quality and R&D Director and has been working in the pharmaceutical and chemistry industry since 2006. Kaspars Kuprevics joined JSC Kalceks in 2015 as a qualified person. He begun working in JSC Grindeks in 2006 as technician in Chromatography Laboratory but gradually extended his career and became the Head of the Quality Control Laboratory.

Related posts

ImgNews4

Grindeks celebrates 75-year anniversary

Today on December 21, JSC Grindeks, the leading pharmaceutical manufacturer in the Baltic States celebrates its 75-year anniversary. Over these 75 years, Grindeks has become...
21/12/2021
magnifiercrossmenu